200 results on '"Miller Christopher A"'
Search Results
2. Somatic mutations and clonal hematopoiesis in congenital neutropenia
3. Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma
4. Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemia
5. Enforced differentiation of Dnmt3a-null bone marrow leads to failure with c-Kit mutations driving leukemic transformation
6. Caspase-9 is required for normal hematopoietic development and protection from alkylator-induced DNA damage in mice
7. A Comprehensive Reassessment of the Direct DNA Binding Sites of PML-Rara within the Genomes of Primary Hematopoietic Progenitor Cells, and Their Effects on Chromatin Structure and Gene Expression
8. Re-Sensitization of Allogeneic T Cell Resistant Murine AML with Pegylated IFN-Gamma
9. Nucleolar Stress Plays a Key Role in the Pathogenesis of T Cell Acute Lymphoblastic Leukemia
10. DNMT3A overgrowth syndrome is associated with the development of hematopoietic malignancies in children and young adults
11. Dnmt3a Inactivation Leads to Slow DNA Methylation Loss in Murine Hematopoietic Cells In Vivo
12. Analysis of the Proteomes of Primary, De Novo Acute Myeloid Leukemia Cells from Adults
13. Adverse Outcomes in Acute Myeloid Leukemia Are Associated with Tumor Cell-Mediated Immunosuppression
14. Tumor suppressor function of Gata2 in acute promyelocytic leukemia
15. Mechanisms of PML::Rara and GATA2 Protein Interactions in Hematopoietic Cells
16. Rapid and Accurate Remethylation of Dnmt3a Deficient Hematopoietic Cells with Restoration of DNMT3A Activity
17. Overexpression of the Signaling Integrator Gab2 Accelerates AML Development in Mice with Dnmt3a R878Hand Npm1 cA Mutations
18. Reduced Subclone Diversity in Clonal Cytopenia of Undetermined Significance Compared to Myelodysplastic Syndrome
19. Signaling Gene Mutations Are Characterized By Diverse Patterns of Expansion and Contraction during Progression from MDS to Secondary AML
20. Molecular Profiling of Decitabine Response in MDS and AML Patients
21. Gata2 Expression and Function in PML-RARA-driven Preleukemia and APL
22. DNMT3AR882 Alters the Epigenome of Hematopoietic Cells
23. The Molecular Basis of Long First Remissions in Normal Karyotype AML Patients
24. DNMT3Aovergrowth syndrome is associated with the development of hematopoietic malignancies in children and young adults
25. Mutational landscape and response are conserved in peripheral blood of AML and MDS patients during decitabine therapy
26. Tumor suppressor function of Gata2in acute promyelocytic leukemia
27. Rapid expansion of preexisting nonleukemic hematopoietic clones frequently follows induction therapy for de novo AML
28. The Role of Transcription Factor and Signaling Gene Mutations in the Clonal Evolution of MDS to Secondary AML
29. Evidence for Complete Mutation Clearance in Normal Karyotype AML Patients with Very Long (> 5 years) Remissions after Chemotherapy Alone
30. Direct Detection of Expressed Mutations in AML Cells Using Single Cell RNA-Sequencing, and Its Impact on Defining Sources of Expression Heterogeneity
31. An Off-the-Shelf™ Fratricide-Resistant CAR-T for the Treatment of T Cell Hematologic Malignancies
32. A Comparison of an Individualized and Weight-Based Opioid Protocols for the Treatment of Vaso-Occlusive Episodes in the Emergency Department
33. Clonal Evolution Revealed By Exome Sequencing in a Case of Primary Myelofibrosis Associated with Subsequent Development of Aggressive Systemic Mastocytosis/Mast Cell Leukemia
34. Dynamic Changes in MDS Clonal Architecture Following Allogeneic Stem Cell Transplant
35. Clonal Evolution of Acute Myeloid Leukemia Following Allogeneic Stem Cell Transplantation
36. Somatic mutations and clonal hematopoiesis in congenital neutropenia.
37. Overexpression of the Signaling Integrator Gab2Accelerates AML Development in Mice with Dnmt3a R878Hand Npm1 cAMutations
38. Rapid and Accurate Remethylation of Dnmt3aDeficient Hematopoietic Cells with Restoration of DNMT3A Activity
39. Dynamic Changes in Clonal Clearance with Decitabine Therapy in AML and MDS Patients
40. Non-Malignant Oligoclonal Hematopoiesis Commonly Follows Cytoreductive Chemotherapy in Adult De Novo AML Patients
41. Dynamic Changes in the Clonal Structure of MDS and AML in Response to Epigenetic Therapy
42. Downregulation of MHC Class II in Relapsed AML Cells after Allogeneic Transplantation
43. Ultra-Deep Sequencing As a Predictive Tool for MDS Progression after Allogeneic Hematopoietic Cell Transplant
44. Cellular Stressors Contribute to the Expansion of Multiple Hematopoietic Clones of Varying Leukemic Potential
45. Integration of Whole Exome and RNA Sequencing Identifies Neoepitope Vaccine Candidates in >90 Percent of Follicular Lymphoma Patients
46. Enforced Differentiation of Dnmt3a-Null Bone Marrow Leads to Failure with c-Kit Mutations Driving Leukemic Transformation
47. Personalized Approach To Treatment of Acute Myeloid Leukemia Using a High-Throughput Chemosensitivity Assay
48. Subclonal “skewing” Of De Novo AML Samples After Engraftment In Immunodeficient Mice
49. Clonal Evolution Revealed by Whole Genome Sequencing in a Case of Primary Myelofibrosis Transformed to Secondary Acute Myeloid Leukemia
50. Acute Lymphoblastic Leukemia-Associated PAX5 Mutations Induce Aberrant B Cell Development
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.